L084-1868 Screening compound: 2-CYCLOPENTYL-N-METHYL-N-(2-{5-[4-(MORPHOLINE-4-CARBONYL)PHENYL]-124-OXADIAZOL-3-YL}ETHYL)ACETAMIDE

L084-1868 Screening compound: 2-CYCLOPENTYL-N-METHYL-N-(2-{5-[4-(MORPHOLINE-4-CARBONYL)PHENYL]-124-OXADIAZOL-3-YL}ETHYL)ACETAMIDE
L084-1868 Screening compound: 2-CYCLOPENTYL-N-METHYL-N-(2-{5-[4-(MORPHOLINE-4-CARBONYL)PHENYL]-124-OXADIAZOL-3-YL}ETHYL)ACETAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound L084-1868
2-CYCLOPENTYL-N-METHYL-N-(2-{5-[4-(MORPHOLINE-4-CARBONYL)PHENYL]-124-OXADIAZOL-3-YL}ETHYL)ACETAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L084-1868

Molecular Formula

C23H30N4O4 (C23 H30 N4 O4)

Compound Name

2-CYCLOPENTYL-N-METHYL-N-(2-{5-[4-(MORPHOLINE-4-CARBONYL)PHENYL]-124-OXADIAZOL-3-YL}ETHYL)ACETAMIDE

IUPAC name

2-cyclopentyl-N-methyl-N-(2-{5-[4-(morpholine-4-carbonyl)phenyl]-124-oxadiazol-3-yl}ethyl)acetamide

SMILES

CN(CCc1noc(-c(cc2)ccc2C(N2CCOCC2)=O)n1)C(CC1CCCC1)=O

InChI

InChI=1S/C23H30N4O4/c1-26(21(28)16-17-4-2-3-5-17)11-10-20-24-22(31-25-20)18-6-8-19(9-7-18)23(29)27-12-14-30-15-13-27/h6-9,17H,2-5,10-16H2,1H3

InChI Key

XUHZWJAHGMZUFN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27229815

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

426.52

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.211

Distribution Coefficient, logD

2.211

Water Solubility, LogSw

-2.56

Polar Surface Area

73.623

Acid Dissociation Constant (pKa)

23.39

Base Dissociation Constant (pKb)

-0.17

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

56.52

L084-1868 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

PI3K-Targeted Library (17255 compounds)

Targeted Diversity Library (40567 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Antiviral
  • Infections
  • Immune system
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L084-1868 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L084-1868?
Check Price and Availability of L084-1868, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L084-1868 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L084-1868
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L084-1868
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L084-1868 available by request